Showing results (1781-1790 of 7,616) with videos related to
Sort By:
Pageof 762
Cornea|November 8, 2021
Congenital Insensitivity to Pain: A Case Report With Corneal Esthesiometry and In Vivo Confocal MicroscopyJeremy D Keenan, John A Gonzales, Stephen G Waxman, et al.Plos One|July 3, 2014
Variation in the visual habitat may mediate the maintenance of color polymorphism in a poeciliid fishJorge L Hurtado-Gonzales, Ellis R Loew, J Albert C UyArthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|June 29, 2012
Extensive heterotopic ossification after suspensory cortical fixation of acute distal biceps tendon rupturesArmando F Vidal, Ryan C Koonce, Michelle Wolcott, et al.Digestive Diseases and Sciences|March 1, 2015
High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency DepartmentsChanda K Ho, Judith H Maselli, Norah A Terrault, et al.Journal of Analytical Toxicology|February 18, 2025
A fully validated LC-QTOF-MS screening workflow for the analysis of drugs in oral fluidCynthia Coulter, Jonah Gonzales, Campbell A Coulter, et al.Obesity (Silver Spring, Md.)|February 18, 2025
Trends in educational inequalities in obesity-attributable mortality in England and Wales, Finland, and ItalyFanny Janssen, Rolando Gonzales Martinez, Nicolás Zengarini, et al.BMC Bioinformatics|November 30, 2024
A novel phenotype imputation method with copula modelJianjun Zhang, Jane Zizhen Zhao, Samantha Gonzales, et al.Psychiatry Research|October 26, 2024
Psychiatric and functional correlates of stigma associated with cognitive impairment in schizophreniaLauren Gonzales, Alice M Saperstein, Min Qian, et al.Healthcare (Basel, Switzerland)|October 25, 2024
Prevalence of Depressive Symptoms in a Predominantly Hispanic/Latinx South Texas Community in the Aftermath of the COVID-19 PandemicYuxia Huang, Zhiyong Hu, Ana Guerrero, et al.Journal of Veterinary Pharmacology and Therapeutics|June 27, 2024
Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitisAndrea J Gonzales, Michelle Aleo, Sean Mahabir, et al.Pageof 762